Why Fibroids Sometimes Return
For many women, treating uterine fibroids brings significant relief from heavy bleeding, pelvic pressure, and chronic discomfort. However, fibroids can sometimes return or new ones may develop over time. At 1Fibroid, serving Manhattan, Queens, and Rego Park, NY, patients often ask why repeat treatment is necessary even after a successful procedure. The answer lies in the nature of fibroids themselves. Fibroids are influenced by hormones such as estrogen and progesterone, and as long as these hormones remain active in the body, new fibroids can form.
It is important to understand that recurrence does not necessarily mean a prior treatment failed. In many cases, the original fibroids were effectively treated, but additional growths developed later. Age, genetic predisposition, number of fibroids, and type of treatment initially performed can all influence the likelihood of recurrence. Women who were younger at the time of their first treatment may have a higher chance of developing new fibroids simply because they have more reproductive years ahead.
Factors That Influence the Need for Repeat Treatment
Several variables play a role in whether a woman might need additional fibroid treatment. The size, number, and location of fibroids are key considerations. For example, women with multiple small fibroids may be more likely to experience regrowth compared to those who had a single isolated fibroid removed. Hormonal factors and family history can also increase recurrence risk.
The type of initial treatment matters as well. Medication can help manage symptoms but typically does not eliminate fibroids permanently. Procedures that shrink fibroids may not remove all fibroid tissue, which can allow some growth to persist over time. Even surgical options such as myomectomy, which removes fibroids while preserving the uterus, carry a known recurrence rate because the uterus remains intact. Understanding these factors helps patients approach repeat treatment decisions with realistic expectations and confidence.
Repeat Non-Surgical and Minimally Invasive Options
When fibroids return, many women prefer to explore less invasive approaches before considering major surgery. Medication may again be used to help control heavy bleeding or pelvic discomfort, particularly if symptoms are mild. Hormonal therapies can provide temporary symptom relief and may be appropriate for women nearing menopause.
Minimally invasive procedures are often strong options for repeat care. Uterine Fibroid Embolization (UFE) can be performed in some women who have had prior surgery, depending on individual circumstances. Other techniques, including radiofrequency-based treatments and targeted approaches, may be considered if fibroids are accessible and appropriately sized. These options typically involve shorter recovery periods compared to open surgery and allow many women to resume normal routines relatively quickly. Careful imaging and evaluation are essential to determine candidacy for repeat minimally invasive treatment.
Surgical Considerations for Recurrent Fibroids
For some women, repeat surgery may offer the most durable relief. A second myomectomy can be considered, particularly for women who wish to preserve fertility. However, repeat surgery may be more complex due to scar tissue from prior procedures. This is why detailed preoperative planning and consultation are crucial.
In cases where fibroids continue to recur and significantly affect quality of life, hysterectomy may be discussed as a definitive solution. While this option is not appropriate for women who wish to maintain fertility, it permanently eliminates the possibility of fibroid recurrence. Each surgical decision should take into account symptom severity, reproductive goals, overall health, and personal preferences.
Making an Informed Decision Moving Forward
Facing repeat fibroid treatment can feel discouraging, but it is important to remember that effective options remain available. Open communication with healthcare providers allows women to revisit goals, reassess symptoms, and explore updated treatment strategies. Advances in medical technology continue to improve outcomes and reduce recovery times, even for repeat procedures.
At 1Fibroid in Manhattan, Queens, and Rego Park, NY, women are encouraged to stay informed and proactive about their reproductive health. Understanding why fibroids can return and knowing the range of available treatment options empowers patients to make thoughtful, individualized decisions that support long-term well-being.
Resources
Stewart, E. A., Cookson, C. L., Gandolfo, R. A., & Schulze-Rath, R. (2017). Epidemiology of Uterine Fibroids. Clinical Obstetrics and Gynecology.
Laughlin-Tommaso, S. K. (2018). Management of Uterine Fibroids. Obstetrics and Gynecology Clinics of North America.
Bulun, S. E. (2013). Uterine Fibroids. New England Journal of Medicine.